We are live on ! Find out more
ACS

Archford Capital Strategies Portfolio holdings

AUM $987M
1-Year Est. Return 29.31%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+29.31%
3 Year Est. Return
+76.21%
5 Year Est. Return
+80.45%
10 Year Est. Return
+551.54%
AUM
$617M
AUM Growth
+$21.4M
Cap. Flow
+$13.1M
Cap. Flow %
2.12%
Top 10 Hldgs %
29.88%
Holding
279
New
20
Increased
129
Reduced
75
Closed
21

Top Buys

Rank Stock Value
1
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$4.66M
2
V icon
Visa
V
+$1.89M
3
ACN icon
Accenture
ACN
+$1.7M
4
AME icon
Ametek
AME
+$1.44M
5
AAPL icon
Apple
AAPL
+$1.35M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$1.69M
2
NVS icon
Novartis
NVS
+$1.36M
3
ABBV icon
AbbVie
ABBV
+$1.27M
4
ADI icon
Analog Devices
ADI
+$1.14M
5
UNP icon
Union Pacific
UNP
+$1.13M

Sector Composition

Rank Sector Weight
1 Technology 15.46%
2 Healthcare 4.55%
3 Financials 4.21%
4 Industrials 3.3%
5 Consumer Discretionary 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPG icon
251
PPG Industries
PPG
$25.5B
$205K 0.03%
1,626
MO icon
252
Altria Group
MO
$107B
$202K 0.03%
+4,441
New +$197K
SFLR icon
253
Innovator Equity Managed Floor ETF
SFLR
$2.15B
$201K 0.03%
+6,520
New +$195K
HELO icon
254
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
$4.73B
$201K 0.03%
+3,430
New +$194K
NAD icon
255
Nuveen Quality Municipal Income Fund
NAD
$2.75B
$195K 0.03%
16,604
PACB icon
256
Pacific Biosciences
PACB
$345M
$72.2K 0.01%
52,695
-18,063
-26% -$36.5K
BNGO icon
257
Bionano Genomics
BNGO
$13.8M
$47.2K 0.01%
1,159
AMLI
258
DELISTED
American Lithium Corp. Common Stock
AMLI
$5.83K ﹤0.01%
10,500
ADSK icon
259
Autodesk
ADSK
$52.7B
-4,243
Closed -$1.1M
ARKG icon
260
ARK Genomic Revolution ETF
ARKG
$1.79B
-11,764
Closed -$338K
BDX icon
261
Becton Dickinson
BDX
$50B
-915
Closed -$226K
BHP icon
262
BHP
BHP
$229B
-9,231
Closed -$533K
CAH icon
263
Cardinal Health
CAH
$54.5B
-1,903
Closed -$213K
CNRG icon
264
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$208M
-5,181
Closed -$336K
LYB icon
265
LyondellBasell Industries
LYB
$20.3B
-6,219
Closed -$636K
NTRS icon
266
Northern Trust
NTRS
$35B
-7,059
Closed -$628K
NVS icon
267
Novartis
NVS
$290B
-14,073
Closed -$1.36M
O icon
268
Realty Income
O
$59.2B
-3,757
Closed -$203K
QQQE icon
269
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.43B
-11,425
Closed -$1.02M
RCL icon
270
Royal Caribbean
RCL
$82.4B
-3,467
Closed -$482K
SBUX icon
271
Starbucks
SBUX
$124B
-2,242
Closed -$205K
SCHD icon
272
Schwab US Dividend Equity ETF
SCHD
$107B
-7,584
Closed -$204K
SHYG icon
273
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
-4,755
Closed -$202K
SNSR icon
274
Global X Internet of Things ETF
SNSR
$224M
-13,326
Closed -$483K
SNY icon
275
Sanofi
SNY
$105B
-18,979
Closed -$922K

Similar funds

Archford Capital Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, Archford Capital Strategies held 279 positions worth $617M, up 3.6% from $596M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Archford Capital Strategies's Q2 2024 filing shows 20 new, 129 increased, 75 reduced and 21 closed positions. Its largest new stake was Accenture: 5,558 shares worth $1.69M. The largest sale was Philip Morris, an estimated $1.69M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Archford Capital Strategies's largest Q2 2024 buy was Accenture: 5,558 shares worth $1.69M.
  • Archford Capital Strategies added most to iShares 0-1 Year Treasury Bond ETF in Q2 2024, an estimated $4.66M increase.
  • Archford Capital Strategies's biggest Q2 2024 reduction was Philip Morris, cutting an estimated $1.69M.
  • Archford Capital Strategies fully exited Novartis in Q2 2024, selling an estimated $1.36M.
  • Archford Capital Strategies's ten largest holdings make up 30% of its $617M portfolio in Q2 2024.
  • Archford Capital Strategies opened 20 new positions and closed 21 in Q2 2024.
  • Archford Capital Strategies's portfolio value rose 3.6% quarter-over-quarter to $617M.

Based on Archford Capital Strategies's 13F filing for Q2 2024, filed 17 Jul 2024.